Liabilities of Fresenius Medical Care AG from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ifrs-full: EUR
Summary
Fresenius Medical Care AG quarterly Liabilities in EUR history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • Fresenius Medical Care AG Liabilities for the quarter ending 31 Dec 2024 was €17,798,066,000, a 6.8% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (EUR)
Liabilities, YoY Quarterly Change (%)

Fresenius Medical Care AG Quarterly Liabilities (EUR)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 €17,798,066,000 -€1,305,207,000 -6.8% 31 Dec 2024 20-F 25 Feb 2025 2024 FY
Q3 2024 €17,719,858,000 -€2,480,270,000 -12% 30 Sep 2024 6-K 05 Nov 2024 2024 Q3
Q2 2024 €18,708,849,000 -€1,321,103,000 -6.6% 30 Jun 2024 6-K 30 Jul 2024 2024 Q2
Q1 2024 €19,203,772,000 -€1,069,813,000 -5.3% 31 Mar 2024 6-K 07 May 2024 2024 Q1
Q4 2023 €19,103,273,000 -€1,201,662,000 -5.9% 31 Dec 2023 20-F 25 Feb 2025 2024 FY
Q3 2023 €20,200,128,000 -€1,470,929,000 -6.8% 30 Sep 2023 6-K 02 Nov 2023 2023 Q3
Q2 2023 €20,029,952,000 -€589,041,000 -2.9% 30 Jun 2023 6-K 02 Aug 2023 2023 Q2
Q1 2023 €20,273,585,000 +€88,751,000 +0.44% 31 Mar 2023 6-K 09 May 2023 2023 Q1
Q4 2022 €20,304,935,000 -€82,586,000 -0.4% 31 Dec 2022 20-F 20 Feb 2024 2023 FY
Q3 2022 €21,671,057,000 +€1,286,049,000 +6.3% 30 Sep 2022 6-K 31 Oct 2022 2022 Q3
Q2 2022 €20,618,993,000 +€444,221,000 +2.2% 30 Jun 2022 6-K 02 Aug 2022 2022 Q2
Q1 2022 €20,184,834,000 +€225,951,000 +1.1% 31 Mar 2022 6-K 04 May 2022 2022 Q1
Q4 2021 €20,387,521,000 +€1,029,795,000 +5.3% 31 Dec 2021 20-F 22 Feb 2023 2022 FY
Q3 2021 €20,385,008,000 -€8,365,000 -0.04% 30 Sep 2021 6-K 02 Nov 2021 2021 Q3
Q2 2021 €20,174,772,000 -€692,459,000 -3.3% 30 Jun 2021 6-K 30 Jul 2021 2021 Q2
Q1 2021 €19,958,883,000 -€843,608,000 -4.1% 31 Mar 2021 6-K 06 May 2021 2021 Q1
Q4 2020 €19,357,726,000 -€349,772,000 -1.8% 31 Dec 2020 20-F 22 Feb 2022 2021 FY
Q3 2020 €20,393,373,000 +€767,390,000 +3.9% 30 Sep 2020 6-K 29 Oct 2020 2020 Q3
Q2 2020 €20,867,231,000 +€1,711,681,000 +8.9% 30 Jun 2020 6-K 30 Jul 2020 2020 Q2
Q1 2020 €20,802,491,000 +€1,675,791,000 +8.8% 31 Mar 2020 6-K 06 May 2020 2020 Q1
Q4 2019 €19,707,498,000 +€6,367,188,000 +48% 31 Dec 2019 20-F 23 Feb 2021 2020 FY
Q3 2019 €19,625,983,000 +€6,384,741,000 +48% 30 Sep 2019 6-K 31 Oct 2019 2019 Q3
Q2 2019 €19,155,550,000 +€6,088,917,000 +47% 30 Jun 2019 6-K 30 Jul 2019 2019 Q2
Q1 2019 €19,126,700,000 +€5,880,587,000 +44% 31 Mar 2019 6-K 02 May 2019 2019 Q1
Q4 2018 €13,340,310,000 +€143,281,000 +1.1% 31 Dec 2018 20-F 20 Feb 2020 2019 FY
Q3 2018 €13,241,242,000 30 Sep 2018 6-K 30 Oct 2018 2018 Q3
Q2 2018 €13,066,633,000 30 Jun 2018 6-K 01 Aug 2018 2018 Q2
Q1 2018 €13,246,113,000 31 Mar 2018 6-K 03 May 2018 2018 Q1
Q4 2017 €13,197,029,000 -€1,255,379,000 -8.7% 31 Dec 2017 20-F 20 Feb 2019 2018 FY
Q4 2016 €14,452,408,000 31 Dec 2016 20-F 27 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.